iPSC-Based Treatments

What Are They?

Human iPSCs have the unique capability to replicate indefinitely and give rise to all cell types of the human body, including the cell types required for repair.

Since Japanese researcher Dr. Shinya Yamanaka’s Nobel Prize-winning discovery of iPSCs in 2006, they have become a major platform for new regenerative medicine therapies.

How They’re Being Put to Use

Scientists and clinicians are actively developing human iPSC-based treatments for numerous conditions including:

  • Degenerative eye diseases (in clinical trials)
  • Spinal chord injuries
  • Type 1 diabetes
  • Many others
Stemson is the first
to leverage an iPSC approach to treat hair loss by generating de novo hair follicles.

Our Approach to Hair Follicle Regeneration

Using the patient's own cells, Stemson leverages industry standard procedures to generate human iPSCs.

From there, Stemson initiates its proprietary process to differentiate patient-specific iPSCs into the folliculogenic cells required for hair follicle formation.

Then Stemson's proprietary cell transplantation procedure ensures the cells anchor effectively under the skin and grow through the skin to yield a healthy hair follicle.

Using the patient's own cells, Stemson leverages industry standard procedures to generate human iPSCs.

From there, Stemson initiates its proprietary process to differentiate patient-specific iPSCs into the folliculogenic cells required for hair follicle formation.

Then Stemson's proprietary cell transplantation procedure ensures the cells anchor effectively under the skin and grow through the skin to yield a healthy hair follicle.

Advantages of Stemson's Solution

Unlimited Scale
Our iPSC-based solution has the capacity to generate an unlimited supply of folliculogenic cells and hair follicles.
De Novo Follicle Formation
Stemson's solution can deliver a net new supply of hair follicles, unlike today's existing treatments.
Potential to Address Many Forms of Hair Loss
Stemson's unique approach will be able to address Scarring Alopecia, Androgenic Alopecia, and Chemo-induced Alopecia.
Potential for Allogeneic Approach
Using banked iPSC cells, rather than harvesting the patient's own cells, will offer further scalability and superior economics.

Want to Learn More About the Science?

Read our research article, Derivation of Hair-Inducing Cell from Human Pluripotent Stem Cells

Download

Take a look at our page on Hair Follicle Biology for a deeper dive.

Learn More